Anabolism Versus Antiresorption: A Quadruple Labeling Histomorphometry Study to Compare the Mechanism of Action of Teriparatide and Denosumab in Postmenopausal Women With Osteoporosis
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Teriparatide (Primary) ; Calcium; Demeclocycline; Denosumab; Tetracycline; Vitamin D
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms AVA
- Sponsors Eli Lilly and Company
- 09 Feb 2016 Primary endpoint has been met. (Change From Baseline to 3 Months in Mineralizing Surface (MS) /Bone Surface (BS) in the Cancellous Compartment (CC) of the Iliac Crest Bone Biopsies), as per an abstract published in the Journal of Clinical Endocrinology and Metabolism.
- 09 Feb 2016 Results published in the Journal of Clinical Endocrinology and Metabolism
- 30 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.